These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2102701)

  • 21. [Medical maintenance treatment of chronic obstructive pulmonary disease (COPD)].
    Kerstjens HA; Postma DS
    Ned Tijdschr Geneeskd; 2002 Aug; 146(35):1631-5. PubMed ID: 12233157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J; Profant M; Kostrica R; Waskin H
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic obstructive lung diseases and principles of their treatment].
    Pomerantsev VP; Kopalova SM; Maĭchuk EIu
    Klin Med (Mosk); 1985 Dec; 63(12):106-12. PubMed ID: 3912604
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical trial of the efficacy and safety of moguisteine in patients with cough associated with chronic respiratory diseases.
    Aversa C; Cazzola M; Clini V; Dal Negro R; Maiorano V; Tana F; Allegra L
    Drugs Exp Clin Res; 1993; 19(6):273-9. PubMed ID: 8013271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic nonobstructive bronchitis].
    Kokosov AN
    Klin Med (Mosk); 1999; 77(1):11-6. PubMed ID: 10097499
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic obstructive pulmonary disease.
    Kerstjens H; Postma D; ten Hacken N
    Clin Evid; 2006 Jun; (15):2077-100. PubMed ID: 16973079
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
    Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C
    Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Problems of ambulatory drug therapy. 2. Studies on the ambulatory drug therapy of chronic bronchitis with special reference to central therapy recommendations and to chemotherapeutical aspects].
    Altmann J; Walther H; Meyer FP
    Z Arztl Fortbild (Jena); 1972 Mar; 66(5):245-52. PubMed ID: 5039030
    [No Abstract]   [Full Text] [Related]  

  • 29. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of bronchiectasis antibiotic therapy excepted. Non-antibiotic therapy of children and adults].
    Kalendarov D; Hubert D
    Rev Pneumol Clin; 2001 Sep; 57(4 Pt 2):S31-5; discussion S35-6. PubMed ID: 11887437
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of chronic bronchial asthma in the adult.
    Banov CH
    J S C Med Assoc; 1973 Nov; 69(11):426-31. PubMed ID: 4584260
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of itraconazole in the treatment of patients with chronic cough whose sputa yield basidiomycetous fungi-fungus-associated chronic cough (FACC).
    Ogawa H; Fujimura M; Takeuchi Y; Makimura K
    J Asthma; 2009 May; 46(4):407-12. PubMed ID: 19484679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
    Hordvik NL; Sammut PH; Judy CG; Colombo JL
    Pediatr Pulmonol; 2002 Oct; 34(4):287-96. PubMed ID: 12205570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of nebulized fluticasone propionate in adult patients admitted to the emergency department due to bronchial asthma attack.
    Starobin D; Bolotinsky L; Or J; Fink G; Shtoeger Z
    Isr Med Assoc J; 2008; 10(8-9):568-71. PubMed ID: 18847151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
    Starakis I; Gogos CA; Bassaris H
    Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute exacerbations of chronic bronchitis: focusing management for optimum results.
    Aboussouan LS
    Postgrad Med; 1996 Apr; 99(4):89-90, 95-8, 101-2. PubMed ID: 8604417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical evaluation of the therapeutic efficacy of a new antiphlogistic and mucus-regulating drug, guaimesal, in acute and chronic bronchopneumopathies].
    Bandera M; Fioretti M
    Clin Ter; 1984 Sep; 110(5):455-61. PubMed ID: 6238760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.